Related Experiment Video
Updated: Mar 12, 2026
10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.7K
Targeting the TAM Receptors in Leukemia
Madeline G Huey1, Katherine A Minson2, H Shelton Earp3
1Aflac Cancer Center of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta, GA 30322, USA. madeline.huey@emory.edu.
Cancers
|November 12, 2016
Summary
Targeted inhibition of TAM receptor tyrosine kinases offers a novel strategy for treating blood cancers. These kinases drive leukemia growth and drug resistance, making them key therapeutic targets.
Area of Science:
- Oncology
- Hematology
- Molecular Biology
Background:
- The TAM (TYRO-3, AXL, MERTK) family of receptor tyrosine kinases plays crucial roles in immune regulation, cell clearance, and blood cell development.
- Aberrant expression of TAM receptors is observed in various hematologic malignancies, including acute myeloid leukemia and multiple myeloma.
- TAM kinases are implicated in promoting leukemic cell survival and conferring resistance to therapies.
Approach:
- Investigating TAM receptor tyrosine kinases as a therapeutic target for hematologic malignancies.
- Exploring the role of TAM receptors in leukemogenesis and their interplay with oncogenic proteins.
- Developing translational strategies for TAM inhibition, including small molecule inhibitors, ligand traps, and monoclonal antibodies.
Key Points:
- TAM receptors are implicated in innate immune control, NK cell differentiation, efferocytosis, and hemostasis.
- TAM kinases regulate erythropoiesis and megakaryopoiesis.
- TAM receptor expression is linked to leukemic phenotypes and resistance to chemotherapy and targeted agents.
Conclusions:
- Targeted inhibition of TAM receptors presents a promising therapeutic strategy for hematologic malignancies.
- Further research into TAM receptor modulation could enhance anti-tumor immunity and overcome treatment resistance.
- Understanding the bone marrow microenvironment's role is crucial for effective TAM inhibition therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.7K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.7K
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
61
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K